Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Accenture
Mallinckrodt
Daiichi Sankyo
Chubb
Deloitte
Federal Trade Commission
Fish and Richardson

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: RE40640

« Back to Dashboard

Summary for Patent: RE40640
Title:Injectable microfoam containing a sclerosing agent
Abstract: Injectable microfoam for scleroteraphy. The sclerotherapy of varices is based on the injection of liquid substances capable of suppressing them. The present invention relates to the preparation of sclerosing substances in the form of a microfoam. The microfoam is prepared with sclerosing agents, and is then injected in the vein to be treated, so that the microfoam displaces the blood contained in the vein and provides for the contact of the sclerosing agent with the vascular endothelium, with a predetermined known concentration and during a controllable time.
Inventor(s): Garrido; Juan Cabrera (Granada, ES), Garcia-Olmedo; Juan Cabrera (Granada, ES)
Assignee: BTG International Ltd. (London, GB)
Application Number:10/941,013
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent RE40640

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE40640

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Spain9301413Jun 23, 1993

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Citi
Queensland Health
Accenture
Deloitte
Colorcon
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.